CreatorsPublishersAdvertisers
View more in
Cancer

'Urgent' Need to Understand ImmunotherapyDe-escalation in NSCLC

Medscape News
 29 days ago

Cover picture for the articleA growing body of research suggests there may be an optimal duration of immunotherapy for patients with non-small cell lung cancer (NSCLC), after which it can be de-escalated or discontinued to minimize toxicity and costs while maintaining long-term efficacy. However, the research to date does not provide a clear picture...

www.medscape.com

Comments / 0

Comments / 0